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PFTsAbstract Objectives: To determine whether MDCT reﬂects the severity of chronic obstructive
pulmonary disease (COPD) compared to the pulmonary function tests (PFTs).
Patients and methods: A prospective study included 63 COPD patients. Spirometry was done and
included forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC) and the ratio of forced
expiratory volume in 1 s over forced vital capacity (FEV1/FVC). Patients were grouped according
to GOLD guidelines. MDCT examinations were obtained during full inspiration. The extent of
emphysema was quantiﬁed by using dedicated software. 950 Hounsﬁeld units (HU) used as the
percentage of low-attenuation (%LA) emphysematous areas. Statistical study between PFTs, and
CT emphysema extent was performed.
Results: The study included 26 females and 37 males with a mean age of 53 years. A moderate sig-
niﬁcant relationship was found between lung volume less than 950 HU and FVC, FEV1, and
FEV1/FVC (p< 0.001). Pulmonary function tests revealed that 23.8% had mild restrictive defect,
14.3% had moderate obstructive defect and 61.9% had severe obstructive defect. A good correla-
tion was observed between the quantitative assessments for the lower lung regions with 950 HU
(%LA) and pulmonary function variables (p< 0.001).
Conclusion: MDCT results are signiﬁcantly related to the data of PFTs for deﬁning the severity of
emphysema.
 2014 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V. All
rights reserved.1. Introduction
Pulmonary emphysema is characterized pathologically by an
abnormal enlargement of air spaces distant to the terminal
bronchioles, accompanied by destruction of the alveolar walls.
Chest computed tomography (CT) and pulmonary function
Table 1 Patient characteristics and pulmonary function tests.
Characteristics Mean ± SDs
No. of patients 63
Sex ratio (M/F) 37/26
Age (y) 53 ± 8.9 (35–66)
Smoking 35 patients (10–100 packs-years)
FEV1% 29.8 ± 18.4 (14–56)
FVC% 44.7 ± 19.6 (27–71)
FVC1/FVC% 52.4 ± 16.4 (35–72)
356 H. Atta et al.tests are usually used for the evaluation of emphysema. CT is
widely used not only for an imaging of the radiological assess-
ment of the thorax but also for the functional assessment
including lung density and volume. Particularly, with the
recent advances in multi-detector CT technology, faster volu-
metric data can be acquired easily and used for evaluation of
the volume (1).
Lung volumes are routinely assessed using pulmonary func-
tion tests. These tests allow global measurement of static inspi-
ratory volumes (total lung capacity); static expiratory volumes
(intrathoracic gas volume after normal expiration and the
residual volume after maximum expiration); and dynamic vol-
umes, like the absolute and relative forced expiratory volume
in 1 s (FEV1). However, measurement of unilateral or regional
lung volumes is a major challenge in lung function testing (2).
Computed tomography (CT) yields densitometric measure-
ments that are highly reproducible and that have been
correlated with morphometric measurements of alveolar tissue
(3–6). New scanners require a breath hold of much shorter
duration for imaging. In addition, reconstructions to
1.25 mm for calculation or interpretation can be made without
exposing the patient to additional radiation (7). State-of-the-
art multi-detector CT imaging (MDCT) allows acquisition of
the whole lung in thin sections of 1 mm. These high resolution
3D datasets (HR–MDCT) are mandatory to distinguish paren-
chymal alterations exhibited in emphysema and to assess regio-
nal variations (8). Low attenuation areas on CT represent
macroscopic and microscopic emphysematous changes of the
lung (9). Objective quantiﬁcation of emphysema can be
obtained by measuring the relative lung area occupied by
pixels with attenuation coefﬁcients below a predetermined
threshold (10–12). Quantitative evaluation of emphysema
will be a key feature for serial follow-up examinations of
patients with chronic obstructive pulmonary disease (COPD)
(13,14).
The purpose of this study is to determine whether three-
dimensional CT densitometry reﬂects the severity of chronic
obstructive pulmonary disease compared to the pulmonary
function.Table 2 Correlation between the pulmonary function tests
and extent of emphysema (%LA) below 950 HU.
FVC% FEV1% FEV1/FVC%
Extent of emphysema (950 HU)
Right upper lobe r value .252* .205 .317*
p value .046 .106 .011
Middle lung lobe r value .236 .199 .346**2. Methods and materials
2.1. Patient population
A prospective study included 63 consecutive patients with clin-
ical suspicion of COPD, between August 2011 and December
2012.
The study was approved by the local ethics committee. All
subjects were informed prior to the investigation.p value .062 .117 .005
Right lower lung lobe r value .622** .589** .735**
p value .000 .000 .000
Left upper lobe r value .029 .007 .250*
p value .821 .954 .049
Left lower lobe r value .865** .867** .659**
p value .000 .000 .000
Data given are r-squared (R2) value.
* p value <0.05.
** p value <0.001.2.2. Pulmonary function tests (PFTs)
Pulmonary function tests expressed as percentages of the pre-
dicted values based on age, sex, height and weight, were com-
pleted within 1 week before or after MDCT scanning.
Spirometry was obtained in all subjects and included forced
expiratory volume in 1 s (FEV1), forced vital capacity (FVC)
and the ratio of forced expiratory volume in 1 s over forced
vital capacity (FEV1/FVC). For descriptive purposes, COPD
subjects were staged according to GOLD guidelines (15).2.3. Computed tomography
2.3.1. MDCT acquisition parameters
Multi-detector CT examinations were performed by using
eight-multi-detector row (lightspeed–GE) in single breath-hold
spiral technique without the need for intravascular contrast
material. Scans were obtained during full inspiration while
the patient was in supine position, with the following parame-
ters: 120 kVp, 250 mAs, 2.5 mm collimation, 5-mm slice thick-
ness, 1.25-mm reconstruction increment, and a pitch of 1 with
a standard reconstruction algorithm. Scan volumes were
extended craniocaudally from the thoracic inlet to the level
of the diaphragms and were acquired in one breath-hold per-
iod. The average DLP was 440 (mGy-cm).
2.3.2. Quantitative MDCT image analysis
All raw data were transferred to advantage workstation (AW)
where thoracic VCAR imaging software was used for CT esti-
mation of emphysema. Lungs were segmented from the tho-
racic wall, the heart, and main pulmonary vessels, followed
by segmentation of the individual lobes and the airways. The
software provides automatic segmentation of the lungs and
automatic segmentation and tracking of the airway tree. The
software provides quantiﬁcation of Hounsﬁeld units and a col-
our-coded display of the thresholds within a segmented region.
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tion using an automated ‘‘density mask’’ technique in which
voxels with attenuation values below a speciﬁc threshold are
highlighted. The cut-off level between normal lung density
and abnormal low-attenuation lung was deﬁned as 950
Hounsﬁeld units (HU), because this value accurately predicts
the macroscopic and microscopic extent of emphysema
(16,17). The percentage of low-attenuation (%LA) emphyse-
matous destruction was calculated for the whole lung.
2.4. Statistical analysis
Statistical analysis was performed with SPSS software (SPSS
version 16). The results expressed as mean ± SD for patient
characteristics and CT extent of emphysema, and pulmonary
function. Pearson’s correlation was performed between pul-
monary function data, and CT emphysema extent. A value
of p< 0.05 was considered statistically signiﬁcant. Multiple
comparisons (post hoc test) were done between groups follow-
ing ANOVA test in order to determine which groups differ
from each other. The mean difference was signiﬁcant at the
0.05 level.Table 3 Multiple statistical comparison between different study gro
Dependent variable (I) Pulmonary
function
(J) Pulmonary fun
Total volume upper right
lobe
Mild restrictive Moderate obstruc
Very severe obstru
Moderate obstructive Mild restrictive
Very severe obstru
Very severe obstructive Mild restrictive
Moderate obstruc
Total volume middle
lung lobe
Mild restrictive Moderate obstruc
Very severe obstru
Moderate obstructive Mild restrictive
Very severe obstru
Very severe obstructive Mild restrictive
Moderate obstruc
Total volume lower lung
lobe
Mild restrictive Moderate obstruc
Very severe obstru
Moderate obstructive Mild restrictive
Very severe obstru
Very severe obstructive Mild restrictive
Moderate obstruc
Total volume upper left
lung lobe
Mild restrictive Moderate obstruc
Very severe obstru
Moderate obstructive Mild restrictive
Very severe obstru
Very severe obstructive Mild restrictive
Moderate obstruc
Total volume lower left
lung lobe
Mild restrictive Moderate obstruc
Very severe obstru
Moderate obstructive Mild restrictive
Very severe obstru
Very severe obstructive Mild restrictive
Moderate obstruc
Multiple comparisons between groups using post hoc test.
* The mean difference is signiﬁcant at the 0.05 level.3. Results
3.1. Demographic and clinical characteristics
26 females (41.3%) and 37 males (58.7%) with a mean age
53 ± 8.9 years presented with chronic obstructive lung disease
were included in the study. Their ages ranged from 35 to
66 years. The study included 35 patients who had positive
smoking history (see Table 1).
3.2. Pulmonary function tests
Pulmonary function tests revealed that 15 (23.8%) had mild
restrictive defect, 9 (14.3%) had moderate obstructive defect
and 39 (61.9%) had severe obstructive defect (see Table 1).
3.3. Lung volume
The overall average lung volume was higher among patients
with severe obstructive pulmonary function that was 3.23 L
versus 3.04 L and 1.77 L for moderate obstructive and mildups.
ction Mean
diﬀerence
(I  J)
Std.
error
Sig. 95% Conﬁdence interval
Lower
bound
Upper
bound
tive .44860* .15813 .006 .7649 .1323
ctive .70839* .11395 .000 .9363 .4805
.44860* .15813 .006 .1323 .7649
ctive .25979 .13869 .066 .5372 .0176
.70839* .11395 .000 .4805 .9363
tive .25979 .13869 .066 .0176 .5372
tive 17.68350* .07866 .000 17.5261 17.8409
ctive 17.74042* .05668 .000 17.6270 17.8538
17.68350* .07866 .000 17.8409 17.5261
ctive .05692 .06899 .413 .0811 .1949
17.74042* .05668 .000 17.8538 17.6270
tive .05692 .06899 .413 .1949 .0811
tive .22210* .07273 .003 .3676 .0766
ctive .13793* .05241 .011 .0331 .2428
.22210* .07273 .003 .0766 .3676
ctive .36003* .06379 .000 .2324 .4876
.13793* .05241 .011 .2428 .0331
tive .36003* .06379 .000 .4876 .2324
tive 70.08650* .11718 .000 69.8521 70.3209
ctive 70.79742* .08444 .000 70.6285 70.9663
70.08650* .11718 .000 70.3209 69.8521
ctive .71092* .10277 .000 .5053 .9165
70.79742* .08444 .000 70.9663 70.6285
tive .71092* .10277 .000 .9165 .5053
tive 81.11400* .08878 .000 80.9364 81.2916
ctive 81.66402* .06398 .000 81.5360 81.7920
81.11400* .08878 .000 81.2916 80.9364
ctive .55002* .07787 .000 .3943 .7058
81.66402* .06398 .000 81.7920 81.5360
tive .55002* .07787 .000 .7058 .3943
Fig. 1 A 55-year old female patient had severe obstructive pulmonary function test. (a) Coronal reformat MDCT scan of the chest with
densitometry overlay at a threshold of 950 Hounsﬁeld units and voxels with attenuation below the set threshold are coloured blue. (b)
Three-dimensional volume rendering image shows anatomic segmentation of lungs. (c) %LAA calculated by thoracic imaging software
provides the total low-attenuation volume. Total lung volume was 5.1366 L.
358 H. Atta et al.restrictive ones respectively. A strong correlation was found
between the total lung volume and the pulmonary function
tests (r= 0.97, p< 0.001). Percentage of lung volume with
attenuation values less than 950 HU was 11.47% in patients
with severe obstructive function, and it was 10.32% among
patients with moderate obstructive function compared to
3.66% found among patients with restrictive function. A mod-
erate signiﬁcant relationship was found between lung volume
less than 950 HU and FVC, FEV1, and FEV1/FVC
(p< 0.001) (Tables 2 and 3), (Figs. 1–3).
3.4. Extent of emphysema correlation with pulmonary function
Pearson’s correlation test showed good correlation between
the quantitative assessments for the lower lung regions with
950 HU (%LA) and pulmonary function variables including
FVE1%, FVC% and FEV1/FVC% (p< 0.001). A weak neg-
ative correlation was found between upper lobe and pulmon-
ary function variables (see Table 2).3.5. Difference between groups
For multiple statistical comparisons between different study
groups see Table 3.
4. Discussion
In the present study, we used 950 as %LAA without the use
of intravascular administration of contrast material for quan-
titating emphysema according to work undertaken by Geve-
nois et al. (16,17) and Madani et al. (12) showed that the
950 HU voxel index is the cut-off value for emphysematous
lung parenchyma on CT scans, which corresponds closely with
macroscopic pathological examinations. Watanuki et al. (18)
were the ﬁrst to perform quantitative densitometry of the lung
by measuring the mean value of pixel density in a region of
interest drawn on each scan. Because normal lung at full inspi-
ration has a mean density between 750 and 850 HU (on 10-
mm slices) and emphysema has been deﬁned to be more than 2
Fig. 2 A 60-year female had restrictive pulmonary function test. Coronal reformat shows colour-coded overlay in blue of the
emphysematous area with total lung volume 3.291 L.
Quantitative validation of the severity of emphysema by MDCT 359SD below the normal average density, this gave a value close
to 900 HU as the threshold for calling an area
emphysematous.
In this study, all examinations were performed in full inspi-
ration. No CT examination was done with expiration, as some
authors showed that inspiratory CT is equal to expiratory CT
in the ability to quantify the pulmonary emphysema (19,20). It
is consistent with Gevenois et al. (17) who showed that expira-
tory quantitative CT is not as accurate as inspiratory CT to
measure lung emphysema. Moreover, the patients having difﬁ-
culty in breathing can tolerate the inspiratory CT better than
expiratory CT.
In the present study, a good correlation was observed
between the total lung volume and pulmonary function vari-
ables in inspiratory CT (r= 0.97). Similar good correlation
was found using inspiratory CT (r= 0.84) (21) and
(r= 0.92) (22). As Choroman´ska et al. (23) reported, the total
lung volume can be assessed with the thresholds 1024 and
200 HU. Within the total lung volume, the functional lung
parenchyma has the attenuation values in range 700 to
900 HU and the non-functional lung parenchyma between
1024 and 900 HU represents emphysema. The greater the
proportion of lung attenuation values below 900 HU, themore extensive the emphysema. This is similar to our results
as a signiﬁcant relationship was found among the studied
groups regarding the volume of emphysematous areas and
the severity of pulmonary function tests in patients with severe
obstructive function compared to those with moderate
obstructive and restrictive functions (p< 0.001). Also Choro-
man´ska et al. (23) reported evident correlation between pul-
monary function tests and the total amount of
emphysematous parenchyma has been shown as well as
between pulmonary function tests and the distribution of these
changes in the lungs.
In the present study we found excellent relationship
between the pulmonary function tests and quantitative assess-
ments for the lower lung regions with 950 HU (%LA) that
was in agreement with Gurney et al. who studied emphysema
distribution and showed that predominantly lower lobe zones
of emphysema are more likely to correlate with the results of
pulmonary function tests than is the extent of emphysema in
the upper lung zone, even if the upper lung is more severely
affected. Gurney et al. tried to explain this phenomenon stat-
ing that probably upper lung zones are relatively silent regions
where great emphysematous destruction can be made before
affecting functional tests whereas the presence and degree of
Fig. 3 A 56-year male had severe obstructive pulmonary function test. Coronal reformat shows colour-coded overlay in blue of the
emphysematous area with total lung volume 4.5819 L.
360 H. Atta et al.emphysema in the lower lung zones have a stronger inﬂuence
on the pulmonary function tests, because of loss of perfusion
to the lower lobes (24).
In conclusion, multi-detector computed tomography with
automated three-dimensional CT densitometry deﬁning the
severity of emphysema that is signiﬁcantly related to the vari-
ables of pulmonary function tests and it can provide an alter-
native dependable non invasive investigation for assessment of
severity of emphysema.
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